ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching.

D. Li,1 O. Timofeeva,1 M. Awwad,1 C. Cody,2 S. Najjar,2 S. Rosen-Bronson.1

1Histocompatibility Laboratory, MedStar Georgetown University Hospital, Washington, DC
2MedStar Heart Institute, Washington Hospital Center, Washington, DC

Meeting: 2017 American Transplant Congress

Abstract number: 36

Keywords: Antibodies, Epitopes, Heart, HLA antigens

Session Information

Session Name: Concurrent Session: Heart Waitlist and Allocation: Working to Get It Right

Session Type: Concurrent Session

Date: Sunday, April 30, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: E267

Purpose: Virtual crossmatch (VXM) has been utilized in heart transplant (txp) for more than a decade. Many labs base the VXM solely on single antigen bead (SAB) results; however SAB assays are prone to false negative (FN) results due to prozone-like effects from endogenous complement or antibody (Ab) against public or shared epitopes. False positive (FP) results due to reactivity with cryptic epitopes on denatured HLA antigens (Ags) are also common. Therefore to avoid erroneous VXM interpretation, it is critical to inactivate complement prior to testing and to use multiple solid phase immunoassay (SPI) platforms.

Methods: We retrospectively studied 45 consecutive heart txps. In order to define unacceptable Ags for VXM, patients (pts) were tested using Flow PRA Screen, LabScreen PRA (LSPRA) and SAB (One Lambda Inc). All sera were pre-treated with EDTA to inactivate complement in order to avoid FN reactions. FP reactions were ruled out through analysis of parallel SAB and phenotype-based LSPRA assays. All sera were evaluated for the presence of Ab to shared epitopes. Potential Ab to shared epitopes was identified through comparison of flow PRA Screen and SAB results. When discrepancies were identified, epitope analyses were performed using the HLA Epitope Registry. A positive VXM was defined as the presence of donor specific Ab.

Results: 45 pts were studied, 17 (38%) were HLA Ab positive, 10 (22%) had FP Ab. Of the pts with Ab, 6 (35%) had reactivity with a public or shared epitope. Our flow crossmatch (FXM) results showed 100% correlation with VXM.Conclusion: Accurate VXM can only be achieved using multiple SPI platforms. If Ab assignment is based solely on SAB results from untreated sera, unpredicted positive FXMs will be encountered and a significant number of pts could be inappropriately denied txp due to FP Ab assignments. In addition, use of multiple SPI platforms can be critical to recognize the presence, and assess the strength, of Ab against shared epitopes.

CITATION INFORMATION: Li D, Timofeeva O, Awwad M, Cody C, Najjar S, Rosen-Bronson S. Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Li D, Timofeeva O, Awwad M, Cody C, Najjar S, Rosen-Bronson S. Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/precise-antibody-characterization-using-multiple-solid-phase-assay-platforms-is-critical-for-accurate-virtual-crossmatching/. Accessed June 2, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences